Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?

Group 1 - Siga Technologies Inc. (SIGA) is a notable stock in the Medical sector, currently outperforming the sector with a year-to-date return of approximately 15.5% compared to the sector average of 0.3% [4] - The Zacks Rank for Siga Technologies Inc. is 2 (Buy), indicating a favorable outlook based on earnings estimate revisions and improving earnings outlooks [3] - The Zacks Consensus Estimate for SIGA's full-year earnings has increased by 3% over the past quarter, reflecting stronger analyst sentiment [4] Group 2 - Siga Technologies Inc. is part of the Medical - Drugs industry, which consists of 172 companies and is currently ranked 71 in the Zacks Industry Rank; this industry has seen an average loss of 4% year-to-date [6] - Another stock in the Medical sector, AnaptysBio, Inc. (ANAB), has a year-to-date return of 7.8% and a Zacks Rank of 2 (Buy), with its consensus EPS estimate increasing by 11.9% over the past three months [5][6] - The Medical - Biomedical and Genetics industry, to which AnaptysBio belongs, has a current ranking of 63 and has experienced a year-to-date decline of 6.6% [6]